---
authors:
- Coppenrath, Valerie
- Mazyck, Beth
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/39172681/
file_path: 2024/08/tirzepatide-zepbound-for-the-treatment-of-obesity.md
issue: '2'
keywords:
- Obesity
- Humans
- Anti-Obesity Agents
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Obesity
- Anti-Obesity Agents
original_format: PubMed
pages: 199-200
patient_population: Adults
peer_reviewed: true
pmid: '39172681'
processed_date: '2025-07-30'
publication_date: '2024-08-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Tirzepatide (Zepbound) for the Treatment of Obesity.
topics:
- Family Medicine
volume: '110'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '39172681'
  title: Tirzepatide (Zepbound) for the Treatment of Obesity.
  authors:
  - last_name: Coppenrath
    fore_name: Valerie
    initials: V
    affiliation: UMass Memorial HealthAlliance Fitchburg Family Practice, Fitchburg,
      Massachusetts.
  - last_name: Mazyck
    fore_name: Beth
    initials: B
    affiliation: UMass Memorial HealthAlliance Fitchburg Family Practice, Fitchburg,
      Massachusetts.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '110'
    issue: '2'
  publication_info:
    year: '2024'
    month: 08
    full_date: '2024-08-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Obesity
    major_topic: true
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Anti-Obesity Agents
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  publication_types: *id001
related_articles:
- pmid: '39172681'
  title: Tirzepatide (Zepbound) for the Treatment of Obesity.
  authors:
  - name: Coppenrath V
    authtype: Author
    clusterid: ''
  - name: Mazyck B
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2024 Aug
- pmid: '37966831'
  title: FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management.
  authors:
  - name: Abbasi J
    authtype: Author
    clusterid: ''
  source: JAMA
  pubdate: 2023 Dec 12
- pmid: '39137182'
  title: 'Table: GLP-1 and GIP/GLP-1 receptor agonists for chronic weight management.'
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2024 Aug 5
- pmid: '35658024'
  title: Tirzepatide Once Weekly for the Treatment of Obesity.
  authors:
  - name: Jastreboff AM
    authtype: Author
    clusterid: ''
  - name: Aronne LJ
    authtype: Author
    clusterid: ''
  - name: Ahmad NN
    authtype: Author
    clusterid: ''
  - name: Wharton S
    authtype: Author
    clusterid: ''
  - name: Connery L
    authtype: Author
    clusterid: ''
  - name: Alves B
    authtype: Author
    clusterid: ''
  - name: Kiyosue A
    authtype: Author
    clusterid: ''
  - name: Zhang S
    authtype: Author
    clusterid: ''
  - name: Liu B
    authtype: Author
    clusterid: ''
  - name: Bunck MC
    authtype: Author
    clusterid: ''
  - name: Stefanski A
    authtype: Author
    clusterid: ''
  - name: SURMOUNT-1 Investigators
    authtype: CollectiveName
    clusterid: ''
  source: N Engl J Med
  pubdate: 2022 Jul 21
- pmid: '38630499'
  title: Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity-Reply.
  authors:
  - name: Aronne LJ
    authtype: Author
    clusterid: ''
  - name: SURMOUNT-4 Investigators
    authtype: CollectiveName
    clusterid: ''
  source: JAMA
  pubdate: 2024 May 21
---

# Tirzepatide (Zepbound) for the Treatment of Obesity.

**Authors:** Coppenrath, Valerie, Mazyck, Beth

**Published in:** American family physician | Vol. 110, No. 2 | 2024-08-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/39172681/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Obesity, Anti-Obesity Agents

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/39172681/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
